ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.320
-0.020 (-1.49%)
Jun 9, 2026, 4:00 PM EDT - Market closed
ABVC BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -9.12 | -8.38 | -5.26 | -8.28 | -16.31 | -12.04 |
Depreciation & Amortization | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 |
Stock-Based Compensation | 4.88 | 4.14 | 2.77 | 0.19 | 7.04 | 5.31 |
Other Adjustments | 0.77 | 1.84 | 1.05 | 3.39 | 1.22 | 0.73 |
Change in Receivables | - | - | - | 0.23 | -0.61 | -0.12 |
Changes in Inventories | -0.01 | -0.01 | - | - | - | -0.03 |
Changes in Accounts Payable | - | - | - | - | - | -0.02 |
Changes in Accrued Expenses | 0.13 | 0.15 | 0.15 | 0.64 | 1.61 | -0.17 |
Changes in Income Taxes Payable | -0.01 | 0.01 | -0.11 | 0.11 | - | - |
Changes in Unearned Revenue | - | -0.07 | 0 | 0.07 | - | -0 |
Changes in Other Operating Activities | -0.59 | -0.7 | -0.45 | -0.56 | -0.36 | -1.27 |
Operating Cash Flow | -3.34 | -2.99 | -1.81 | -4.19 | -7.4 | -7.6 |
Capital Expenditures | - | - | - | -0.02 | -0.12 | -0.02 |
Purchases of Investments | -0.68 | - | - | - | - | -0.11 |
Other Investing Activities | -0.07 | -1.21 | - | -0.34 | -1.6 | -0.68 |
Investing Cash Flow | -1.16 | -1.21 | - | -0.36 | -1.72 | -0.81 |
Short-Term Debt Issued | - | - | - | - | 0.35 | 0 |
Short-Term Debt Repaid | -0.75 | -0.12 | -0.03 | -1 | - | -0.1 |
Net Short-Term Debt Issued (Repaid) | -0.75 | -0.12 | -0.03 | -1 | 0.35 | -0.1 |
Long-Term Debt Issued | 0.73 | 0.89 | 0.97 | 1.28 | - | 0.24 |
Long-Term Debt Repaid | - | -0.43 | -0.33 | - | - | -0.41 |
Net Long-Term Debt Issued (Repaid) | 0.73 | 0.46 | 0.64 | 1.28 | - | -0.18 |
Issuance of Common Stock | 3.29 | 4.3 | 1.37 | 3.46 | 3.66 | 11.12 |
Repurchase of Common Stock | - | - | -0.01 | - | - | - |
Net Common Stock Issued (Repurchased) | 3.29 | 4.3 | 1.37 | 3.46 | 3.66 | 11.12 |
Other Financing Activities | -0.15 | - | - | 0.14 | - | -0.85 |
Financing Cash Flow | 3.87 | 4.64 | 1.98 | 3.87 | 4.01 | 10 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.02 | 0.02 | -0.02 | 0 | -0.07 | -0.03 |
Net Cash Flow | -0.62 | 0.46 | 0.15 | -0.67 | -5.17 | 1.56 |
Free Cash Flow | -3.34 | -2.99 | -1.81 | -4.21 | -7.52 | -7.62 |
FCF Margin | - | - | -355.02% | -2760.64% | -775.23% | -2140.33% |
Free Cash Flow Per Share | -0.15 | -0.15 | -0.15 | -0.97 | -2.37 | -2.40 |
Levered Free Cash Flow | -9.89 | -8.16 | -4.66 | -7.24 | -14.92 | -14.61 |
Unlevered Free Cash Flow | -9.3 | -7.76 | -4.98 | -6.71 | -14.74 | -14.07 |